TELA Bio (TELA) to Release Earnings on Thursday

TELA Bio (NASDAQ:TELA) is projected to post its quarterly earnings results after the market closes on Thursday, March 20th. Analysts expect TELA Bio to post earnings of ($0.24) per share and revenue of $23.17 million for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

TELA Bio Price Performance

NASDAQ TELA opened at $2.27 on Thursday. The stock’s 50-day moving average price is $2.65 and its two-hundred day moving average price is $2.74. The company has a current ratio of 2.62, a quick ratio of 1.81 and a debt-to-equity ratio of 14.22. The company has a market cap of $89.41 million, a PE ratio of -1.34 and a beta of 1.10. TELA Bio has a 1 year low of $2.24 and a 1 year high of $6.50.

About TELA Bio

TELA Bio, Inc, a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.